Applied Therapeutics Company Insiders
APLT Stock | USD 9.63 0.36 3.88% |
Slightly above 86 percent of Applied Therapeutics' insiders are activelly selling. The analysis of the overall insider sentiment regarding Applied Therapeutics suggests that a very large number of insiders are panicking. Applied Therapeutics employs about 37 people. The company is managed by 9 executives with a total tenure of roughly 87 years, averaging almost 9.0 years of service per executive, having 4.11 employees per reported executive.
Applied Therapeutics' Insider Buying Vs Selling
14
Selling | Buying |
Latest Trades
2024-08-14 | Shoshana Shendelman | Disposed 119591 @ 5.93 | View | ||
2024-08-12 | Shoshana Shendelman | Disposed 300000 @ 5.98 | View | ||
2024-06-06 | Shoshana Shendelman | Disposed 61795 @ 4.32 | View | ||
2024-06-04 | Real Estate Equitie Alexandria | Disposed 150000 @ 4.21 | View | ||
2024-03-14 | Shoshana Shendelman | Disposed 318573 @ 5.39 | View | ||
2023-12-01 | Stacy J Kanter | Acquired 30000 @ 2.18 | View | ||
2023-11-30 | Riccardo Perfetti | Disposed 1583 @ 1.97 | View |
Monitoring Applied Therapeutics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Applied |
Applied Therapeutics' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Applied Therapeutics' future performance. Based on our forecasts, it is anticipated that Applied will maintain a workforce of slightly above 40 employees by December 2024.Applied Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.7601) % which means that it has lost $0.7601 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.7339) %, meaning that it created substantial loss on money invested by shareholders. Applied Therapeutics' management efficiency ratios could be used to measure how well Applied Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Applied Therapeutics' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 7.33 in 2024, whereas Return On Tangible Assets are likely to drop (2.29) in 2024. At this time, Applied Therapeutics' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 56.5 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 681.3 K in 2024.Common Stock Shares Outstanding is likely to gain to about 88.5 M in 2024, despite the fact that Net Loss is likely to grow to (90.3 M).
Applied Therapeutics Workforce Comparison
Applied Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,803. Applied Therapeutics holds roughly 37.0 in number of employees claiming about 2.05% of equities under Health Care industry.
Applied Therapeutics Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Applied Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-09-01 | 0.1667 | 1 | 6 | 747,886 | 1,561,111 |
2024-06-01 | 1.0 | 5 | 5 | 480,000 | 400,778 |
2023-12-01 | 1.0 | 10 | 10 | 5,810,000 | 3,371,516 |
2023-09-01 | 0.25 | 1 | 4 | 12,375 | 148,659 |
2023-03-01 | 1.0 | 3 | 3 | 2,814,362 | 26,418 |
2022-09-01 | 1.3529 | 23 | 17 | 682,266 | 482,522 |
2022-06-01 | 20.0 | 20 | 1 | 15,278,311 | 905.00 |
2022-03-01 | 4.3333 | 13 | 3 | 1,013,625 | 319,707 |
2021-09-01 | 0.3 | 6 | 20 | 48,734 | 141,766 |
2021-06-01 | 0.5526 | 21 | 38 | 261,464 | 110,601 |
2021-03-01 | 0.3721 | 16 | 43 | 123,116 | 103,063 |
2020-12-01 | 0.25 | 9 | 36 | 526,855 | 154,880 |
2020-09-01 | 0.1304 | 3 | 23 | 36,461 | 233,539 |
2020-06-01 | 0.2917 | 14 | 48 | 507,603 | 479,512 |
2020-03-01 | 1.5 | 9 | 6 | 2,228,312 | 2,005,423 |
2019-06-01 | 0.6207 | 18 | 29 | 5,088,575 | 5,523,618 |
Applied Therapeutics Notable Stakeholders
An Applied Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Applied Therapeutics often face trade-offs trying to please all of them. Applied Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Applied Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Les Funtleyder | Principal CFO | Profile | |
Constantine Chinoporos | COO Officer | Profile | |
Riccardo MD | Chief Officer | Profile | |
Chids Mahadevan | Sr Officer | Profile | |
Steven Ortega | Chief Officer | Profile | |
Catherine Thorpe | Chief Officer | Profile | |
Adam Hansard | Chief Officer | Profile | |
Corwin Hooks | Chief Officer | Profile | |
Shoshana Shendelman | Founder, Directors | Profile |
About Applied Therapeutics Management Performance
The success or failure of an entity such as Applied Therapeutics often depends on how effective the management is. Applied Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Applied management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Applied management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.18) | (2.29) | |
Return On Capital Employed | 3.95 | 4.14 | |
Return On Assets | (2.18) | (2.29) | |
Return On Equity | 6.98 | 7.33 |
Please note, the imprecision that can be found in Applied Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Applied Therapeutics. Check Applied Therapeutics' Beneish M Score to see the likelihood of Applied Therapeutics' management manipulating its earnings.
Applied Therapeutics Workforce Analysis
Traditionally, organizations such as Applied Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Applied Therapeutics within its industry.Applied Therapeutics Manpower Efficiency
Return on Applied Therapeutics Manpower
Revenue Per Employee | 270.1K | |
Revenue Per Executive | 1.1M | |
Net Loss Per Employee | 3.2M | |
Net Loss Per Executive | 13.3M |
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.